HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Blanchet, M-R. Articles by Cormier, Y. Search for Related Content PubMed PubMed Citation Articles by Blanchet, M-R. Articles by Cormier, Y.

Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist

Unité de Recherche, Centre de Pneumologie de l'Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Québec, Canada.

CORRESPONDENCE: Y. Cormier, Hôpital Laval, 2725 Chemin Ste-Foy, Québec City, Québec, Canada G1V 4G5. Fax: 1 4186564762. E-mail: yvon.cormier@med.ulaval.ca

Keywords: Airway resistance, asthma, inflammation, intracellular calcium, nicotinic receptor agonists

Received: October 7, 2004
Accepted April 4, 2005

Nicotinic agonists, including 1,1-dimethyl-4-phenylpiperazinium (DMPP), have anti-inflammatory properties and in some instances smooth muscle relaxing effects. Since inflammation and airway smooth muscle contraction are two major components of asthma, the present authors investigated the effects of DMPP on airway inflammation and airway resistance in a mouse model of asthma.

Mice were sensitised and challenged with ovalbumin (OVA) and treated either intraperitoneally or intranasally with DMPP. The effect of DMPP was tested on airway inflammation, airway resistance and on the increase of intracellular calcium in bronchial smooth muscle cells.

DMPP given either during sensitisation, OVA challenges or throughout the protocol prevented lung inflammation and decreased the serum level of OVA specific immunoglobulin E. DMPP administration reduced the number of total cells, lymphocytes and eosinophils in the bronchoalveolar lavage (BAL) fluid. Intranasal DMPP administration was as effective as dexamethasone (DEXA) in reducing total cell count and eosinophil counts in BAL fluid. DMPP, but not DEXA, reduced tissue inflammation. Intranasal DMPP, given 10 min before the test, reduced airway responsiveness to metacholine. DMPP also reduced the increase in intracellular calcium in response to bradykinin.

In conclusion, these results show that 1,1-dimethyl-4-phenylpiperazinium reduces lung inflammation and prevents airway hyperresponsiveness in the mouse model of asthma.

This article has been cited by other articles:

				M.-R. Blanchet, S. Maltby, D. J. Haddon, H. Merkens, L. Zbytnuik, and K. M. McNagny CD34 facilitates the development of allergic asthma Blood, September 15, 2007; 110(6): 2005 - 2012. [Abstract] [Full Text] [PDF]

				M.-R. Blanchet, A. Langlois, E. Israel-Assayag, M.-J. Beaulieu, C. Ferland, M. Laviolette, and Y. Cormier Modulation of eosinophil activation in vitro by a nicotinic receptor agonist J. Leukoc. Biol., May 1, 2007; 81(5): 1245 - 1251. [Abstract] [Full Text] [PDF]

				M.-R. Blanchet, E. Israel-Assayag, P. Daleau, M.-J. Beaulieu, and Y. Cormier Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activation Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L757 - L763. [Abstract] [Full Text] [PDF]

				I. C. Allen, J. M. Hartney, T. M. Coffman, R. B. Penn, J. Wess, and B. H. Koller Thromboxane A2 induces airway constriction through an M3 muscarinic acetylcholine receptor-dependent mechanism Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L526 - L533. [Abstract] [Full Text] [PDF]